Arcturus Therapeutics Holdings Inc. Share Price Today, Forecast Target, Chat & Where To Buy [ARCT]

Home > Share Prices > Arcturus Therapeutics Holdings Inc. share price (ARCT)

Today's Arcturus Therapeutics Holdings Inc. share price is 22.17 (as of 16:00 26-Sep-2025) which is a change of 1.86 or 9.16% from the last closing price of 22.17 with 915,677 shares traded giving Arcturus Therapeutics Holdings Inc. a market capitalisation of 602,015,710. The most recent daily high has been 22.4 and daily low 20.51. The Arcturus Therapeutics Holdings Inc. share price 52 week high has been 25.88 and the 52 week low 8.04. Based on the most recent Arcturus Therapeutics Holdings Inc. share price opening of 22.17, the current Arcturus Therapeutics Holdings Inc. EPS (earnings per share) are -2.22 and the PE (price earnings ratio) is n/a.

Featured Brokers For Buying Arcturus Therapeutics Holdings Inc. Shares

It currently costs 22.17 to buy one share in Arcturus Therapeutics Holdings Inc. (as of 16:00 26-Sep-2025) which is a change of 1.86 or 9.16% from the last closing price of 20.31. To buy shares in Arcturus Therapeutics Holdings Inc. you will need a stock trading platform like Interactive Brokers, IG or AJ Bell.

You can buy these shares in either a general investment account, stocks & shares ISA or SIPP for your pension with one of the brokers below.

We have ranked, compared and reviewed some of the best share-dealing platforms and accounts in the UK that are regulated by the Financial Conduct Authority (FCA). The main things to compare when choosing a share dealing account are the costs of buying and selling shares (trading fees) and how much it will cost to keep those shares on your account. You should also compare account types so you have the option to deal shares in a tax-efficient ISA, SIPP or for your children.

Is Arcturus Therapeutics Holdings Inc. A Good Investment?

The below Arcturus Therapeutics Holdings Inc. share price analysis and market data includes key financials, earnings estimates, peer performance, dividends, news and a company profile that will give you an indication as to whether this stock is a buy, sell or hold.

Tell us what you think:

Scroll to Top